Project Details
Description
Randomized, Placebo-Controlled, Double-Blind Study to Assess Clinical and Antiviral Activity of Valomaciclovir (EPB 348) in Infectious Mononucleosis Due to Primary Epstei
Status | Finished |
---|---|
Effective start/end date | 11/26/07 → 12/30/09 |
Funding
- EPIPHANY PHARM
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.